Clinical trial
Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis…
NCT00249431 · New York State Psychiatric Institute, Other · Terminated
Key facts
| NCT number | NCT00249431 |
|---|---|
| Title | Effectiveness of Sertraline in Treating Pathological Gamblers With a Diagnosis of Alcohol Dependence - 1 |
| Official title | A Pilot Study of Sertraline Plus Relapse Prevention Therapy (RP) for the Treatment of Pathological Gambling With Comorbid Abuse or Dependence |
| Lead sponsor | New York State Psychiatric Institute, Other |
| Collaborators | National Institute on Drug Abuse (NIDA) NIH |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alcoholism, Gambling |
| Intervention type | Behavioral, Drug |
| Interventions | Sertraline, Relapse Prevention Therapy |
| Enrollment | 9 |
| Start date | Dec 1, 2001 |
| Primary completion | Dec 1, 2005 |
| Completion | Dec 1, 2005 |
| First posted | Nov 7, 2005 |
| Last update posted | Oct 27, 2017 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: